PHOENIX, April 28, 2021 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (“Item 9 Labs” or the “Company”), a vertically integrated cannabis dispensary franchisor and operator that produces premium award-winning products, today announced that the Company will participate in the A.G.P. Spring Consumer Cannabis Conference and the Benzinga Global Small Cap Conference in May 2021.
“The U.S. cannabis market is poised for substantial growth,” said Item 9 Labs CEO Andrew Bowden. “Our Unity Rd. dispensary franchise model, combined with our premium Item 9 Labs products, positions us to benefit both financially and geographically. At these conferences, we will discuss how franchising is the most viable national expansion strategy for our Unity Rd. dispensary brand with greatly reduced capital expenditures, resulting in accelerated scale.”
One-on-One Virtual Meetings at the A.G.P. Spring Consumer Cannabis Conference
– Date: Tuesday, May 4, 2021
– Interested Investors: Please contact your A.G.P. registered representative
Bowden, Chief Strategy Officer Jeffrey Rassás and Chief Franchise Officer Mike Weinberger will be meeting with investors in one-on-one sessions. The conference features up to 30 select companies in the cannabis industry and will be attended by approximately 200 qualified institutional investment funds from around the world.
Presentation at the Benzinga Global Small Cap Conference
– Date: Thursday, May 13, 2021